Bromelain, a natural product, exhibits anti-inflammatory, immunomodulatory, and wound-healing properties. However, its efficacy in treating oral mucosal ulcers remains unexplored. This study aims to evaluate the effect of bromelain as a safe alternate for management of RAS.
Adults aged 18-60 years.
Diagnosed with RAS.
Onset of ulcer within the last 48 hours.
Willingness to participate and provide informed consent.
History of hematological deficiencies, GIT disorders, Behcet's disease and major systemic diseases.
Pregnant or breastfeeding patients.
Previous treatment for the current ulcer episode.